Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 6/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.41 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16086796 | 1.00 | ALDH1A1 (0.50) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL5623597 | 1.00 | ALDH1A1 (0.50) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| Hydrochloric Acid SCHEMBL12478441 | 0.98 | ALDH1A1 (0.48) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| Hydrochloric Acid SCHEMBL28713628 | 0.98 | ALDH1A1 (0.48) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL16086021 | 0.94 | NAAA (0.48) | ALDH1A1ATMTSHRHCAR2NAAA | |
| SCHEMBL16124531 | 0.94 | NAAA (0.48) | ALDH1A1ATMTSHRHCAR2NAAA | |
| SCHEMBL2282981 | 0.94 | NAAA (0.48) | ALDH1A1ATMTSHRHCAR2NAAA | |
| SCHEMBL29163810 | 0.92 | NAAA (0.52) | ALDH1A1TSHRHCAR2NAAALMNA | |
| SCHEMBL1666303 | 0.92 | NAAA (0.52) | ALDH1A1TSHRHCAR2NAAALMNA | |
| SCHEMBL5585033 | 0.92 | NAAA (0.52) | ALDH1A1TSHRHCAR2NAAALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5514671-A | SERINE ALKYL, CYCLOHEXYL OR AROMATIC ETHERS IN VEHICLE; SUPPRESSING BODY ODOR BY APPLYING TO SKIN | THE GILLETTE COMPANY | 1996-05-07 | — | — | US | claimed |
| EP-0644887-A1 | PROCESS FOR THE PREPARATION OF CLAVULANIC ACID. | SMITHKLINE BEECHAM PLC (GB) | 1995-03-29 | — | — | EP | claimed |
| WO-1993025557-A1 | PROCESS FOR THE PREPARATION OF CLAVULANIC ACID | SMITHKLINE BEECHAM PLC (GB) | 1993-12-23 | — | — | WO | claimed |
| EP-0521871-A4 | ALTERNATIVE ENZYME SUBSTRATES AS DEODORANTS | — | 1993-03-10 | — | — | EP | claimed |
| EP-0521871-A1 | ALTERNATIVE ENZYME SUBSTRATES AS DEODORANTS | THE GILLETTE COMPANY (US) | 1993-01-13 | — | — | EP | claimed |
| WO-1991011988-A1 | ALTERNATIVE ENZYME SUBSTRATES AS DEODORANTS | THE GILLETTE COMPANY (US) | 1991-08-22 | — | — | WO | claimed |
| EP-3842443-B1 | METHODS FOR THE SYNTHESIS OF SPHINGOMYELINS AND DIHYDROSPHINGOMYELINS | CERENIS THERAPEUTICS HOLDING SA (FR) | 2025-02-19 | — | — | EP | disclosed |
| CN-116082190-A | Industrial production method of efficient Fmoc-Ser (tBu) -OH | 常州吉恩药业有限公司 | 2023-05-09 | — | — | CN | disclosed |
| CN-105051051-B | Method for synthesizing sphingomyelin and dihydrosphingomyelin | 萨瑞斯治疗控股公司 | 2021-07-16 | — | — | CN | disclosed |
| EP-3842443-A1 | METHODS FOR THE SYNTHESIS OF SPHINGOMYELINS AND DIHYDROSPHINGOMYELINS | Cerenis Therapeutics Holding SA (FR) | 2021-06-30 | — | — | EP | disclosed |
| EP-3363805-B1 | METHODS FOR THE SYNTHESIS OF SPHINGOMYELINS AND DIHYDROSPHINGOMYELINS | CERENIS THERAPEUTICS HOLDING SA (FR) | 2020-12-16 | — | — | EP | disclosed |
| EP-3363805-A1 | METHODS FOR THE SYNTHESIS OF SPHINGOMYELINS AND DIHYDROSPHINGOMYELINS | Cerenis Therapeutics Holding SA (FR) | 2018-08-22 | — | — | EP | disclosed |
| US-20170204122-A1 | METHODS FOR THE SYNTHESIS OF SPHINGOMYELINS AND DIHYDROSPHINGOMYELINS | CERENIS THERAPEUTICS HOLDING SA (FR) | 2017-07-20 | — | — | US | disclosed |
| US-5514671-A | SERINE ALKYL, CYCLOHEXYL OR AROMATIC ETHERS IN VEHICLE; SUPPRESSING BODY ODOR BY APPLYING TO SKIN | THE GILLETTE COMPANY | 1996-05-07 | — | — | US | disclosed |
| EP-0672670-A1 | Process for the preparation of clavulanic acid | SMITHKLINE BEECHAM PLC (GB) | 1995-09-20 | — | — | EP | disclosed |
| EP-0644887-A1 | PROCESS FOR THE PREPARATION OF CLAVULANIC ACID. | SMITHKLINE BEECHAM PLC (GB) | 1995-03-29 | — | — | EP | disclosed |
| WO-1993025557-A1 | PROCESS FOR THE PREPARATION OF CLAVULANIC ACID | SMITHKLINE BEECHAM PLC (GB) | 1993-12-23 | — | — | WO | disclosed |
| EP-0521871-A4 | ALTERNATIVE ENZYME SUBSTRATES AS DEODORANTS | — | 1993-03-10 | — | — | EP | disclosed |
| EP-0521871-A1 | ALTERNATIVE ENZYME SUBSTRATES AS DEODORANTS | THE GILLETTE COMPANY (US) | 1993-01-13 | — | — | EP | disclosed |
| WO-1991011988-A1 | ALTERNATIVE ENZYME SUBSTRATES AS DEODORANTS | THE GILLETTE COMPANY (US) | 1991-08-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170204122-A1 | METHODS FOR THE SYNTHESIS OF SPHINGOMYELINS AND DIHYDROSPHINGOMYELINS | SGMS1, SGMS2, CERS2 | ALDH1A1 2913/4885ATM 4504/4885TSHR 4340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.